Ionis Pharmaceuticals Inc (IONS)
38.72
+1.41
(+3.78%)
USD |
NASDAQ |
May 20, 16:00
38.72
0.00 (0.00%)
After-Hours: 16:49
Ionis Pharmaceuticals Total Long Term Debt (Quarterly): 1.275B for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.275B |
| December 31, 2023 | 1.283B |
| September 30, 2023 | 1.279B |
| June 30, 2023 | 1.315B |
| March 31, 2023 | 1.184B |
| December 31, 2022 | 1.190B |
| September 30, 2022 | 1.224B |
| June 30, 2022 | 1.223B |
| March 31, 2022 | 1.222B |
| December 31, 2021 | 1.232B |
| September 30, 2021 | 1.282B |
| June 30, 2021 | 1.281B |
| March 31, 2021 | 909.79M |
| December 31, 2020 | 908.93M |
| September 30, 2020 | 798.93M |
| June 30, 2020 | 789.18M |
| March 31, 2020 | 779.59M |
| December 31, 2019 | 769.96M |
| September 30, 2019 | 656.25M |
| June 30, 2019 | 646.68M |
| March 31, 2019 | 637.28M |
| December 31, 2018 | 628.06M |
| September 30, 2018 | 619.01M |
| June 30, 2018 | 610.14M |
| March 31, 2018 | 601.42M |
| Date | Value |
|---|---|
| December 31, 2017 | 592.88M |
| September 30, 2017 | 584.49M |
| June 30, 2017 | 516.54M |
| March 31, 2017 | 508.41M |
| December 31, 2016 | 500.51M |
| September 30, 2016 | 408.01M |
| June 30, 2016 | 401.67M |
| March 31, 2016 | 395.46M |
| December 31, 2015 | 389.37M |
| September 30, 2015 | 391.89M |
| June 30, 2015 | 386.32M |
| March 31, 2015 | 380.85M |
| December 31, 2014 | 375.50M |
| September 30, 2014 | 155.44M |
| June 30, 2014 | 153.70M |
| March 31, 2014 | 152.00M |
| December 31, 2013 | 150.33M |
| September 30, 2013 | 148.70M |
| June 30, 2013 | 147.10M |
| March 31, 2013 | 145.53M |
| December 31, 2012 | 143.99M |
| September 30, 2012 | 226.46M |
| June 30, 2012 | 231.05M |
| March 31, 2012 | 220.30M |
| December 31, 2011 | 141.45M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
646.68M
Minimum
Jun 2019
1.315B
Maximum
Jun 2023
1.063B
Average
1.206B
Median
Total Long Term Debt (Quarterly) Benchmarks
| Biogen Inc | 6.540B |
| Viking Therapeutics Inc | -- |
| Madrigal Pharmaceuticals Inc | -- |
| Akero Therapeutics Inc | -- |
| 89bio Inc | -- |